TUESDAY, Nov. 28, 2023 (HealthDay News) — Transgender people transitioning to male (transmasculine) identity typically take testosterone therapy as part of the process.   There have been worries that the treatment might spur erythrocytosis, an abnormally high concentration of red blood cells in blood that could prove dangerous. But newContinue Reading

WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Recent research has suggested that viruses could play a role in the loss of pancreatic beta cells, which triggers type 1 diabetes. Now, a new trial finds antiviral medications, when given soon after a child is diagnosed with type 1 diabetes, might helpContinue Reading

THURSDAY, Sept. 7, 2023 (HealthDay News) — The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots. ExpertsContinue Reading